|
The ornamental design for pill tablet, substantially as shown and described.
|
FIG. 1 is a top view of our pill tablet design;
FIG. 2 is a bottom view thereof;
FIG. 3 is a long side view thereof;
FIG. 4 is an opposite long side view thereof;
FIG. 5 is a short side view thereof;
FIG. 6 is an opposite short side view;
FIG. 7 is a top view showing an embodiment of our pill tablet design;
FIG. 8 is a bottom view thereof;
FIG. 9 is a long side view thereof;
FIG. 10 is an opposite long side view thereof;
FIG. 11 is a short side view thereof;
FIG. 12 is an opposite short side view;
FIG. 13 is a top view showing another embodiment of our pill tablet design;
FIG. 14 is a long side view thereof;
FIG. 15 is an opposite long side view thereof;
FIG. 16 is a short side view thereof;
FIG. 17 is an opposite short side view;
FIG. 18 is a top view showing another embodiment of our pill tablet design;
FIG. 19 is a long side view thereof;
FIG. 20 is an opposite long side view thereof;
FIG. 21 is a short side view thereof; and,
FIG. 22 is an opposite short side view.
Becourt, Philippe, Desesquelle, Christian
Patent | Priority | Assignee | Title |
11279745, | Apr 26 2019 | Novo Nordisk A S | Tolerogenic DNA vaccine |
11466278, | Nov 01 2016 | Novo Nordisk A S | Temperature based plasmid regulation system |
D515202, | Jul 19 2004 | Merck Sharp & Dohme Corp | Tablet |
D553733, | Apr 07 2006 | Novartis AG | Tablet |
D589606, | Jun 03 2008 | Solvay Pharmaceuticals B.V. | Pharmaceutical tablet |
D636865, | Aug 25 2010 | KVK-Tech, Inc. | Pharmaceutical tablet |
D666376, | Dec 01 2010 | Intercontinental Great Brands LLC | Lozenge |
D666377, | Dec 01 2010 | Intercontinental Great Brands LLC | Lozenge |
D735315, | Jun 25 2012 | Amgen Inc | Pharmaceutical tablet |
D741990, | Jul 30 2013 | RB HEALTH US LLC | Tablet |
D744635, | Jun 26 2014 | Access Business Group International LLC | Dietary supplement |
D754840, | Feb 03 2012 | JOHNSON & JOHNSON CONSUMER INC | Oral dosage form |
D754841, | Feb 03 2012 | JOHNSON & JOHNSON CONSUMER INC | Oral dosage form |
D755949, | Jul 30 2013 | RB HEALTH US LLC | Tablet |
D778428, | Feb 03 2012 | JOHNSON & JOHNSON CONSUMER INC | Oral dosage form |
D787042, | Apr 28 2015 | Celgene Corporation | Pharmaceutical tablet |
D787043, | Jun 23 2015 | Celgene Corporation | Pharmaceutical tablet |
D795525, | Mar 16 2016 | Intercontinental Great Brands LLC | Confection |
D813372, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
D821682, | Mar 16 2016 | Intercontinental Great Brands LLC | Confection |
D835257, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
D835258, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
D858741, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
D906513, | Mar 19 2019 | Novo Nordisk A S | Pill |
D907760, | Jan 20 2017 | SOCIÉTÉ DES PRODUITS NESTLÉ S A | Orally ingestible tablet |
D947358, | Mar 19 2019 | Novo Nordisk A/S | Pill |
Patent | Priority | Assignee | Title |
5869096, | Jul 14 1989 | ALZA Corporation | Oral osmotic device with hydrogel driving member |
6027748, | Jan 08 1997 | PAUL ROYALTY FUND, L P | Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption |
6165513, | Jun 11 1997 | Allergan Pharmaceuticals International Limited | Film-coated tablet for improved upper gastrointestinal tract safety |
D301764, | Dec 21 1987 | RHONE-POULENC RORER PHARMACEUTICALS INC | Pharmaceutical tablet |
D302051, | Dec 21 1987 | RHONE-POULENC RORER PHARMACEUTICALS INC | Pharmaceutical tablet |
D403396, | Nov 28 1996 | Astra Aktiebolag | Tablet |
D431076, | Jul 07 1999 | Merck Sharp & Dohme Corp | Tablet |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Sep 24 2001 | Aventis Pharma S.A. | (assignment on the face of the patent) | / | |||
Oct 17 2001 | DESESQUELLE, CHRISTIAN | AVENTIS PHARMA S A | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 012358 | /0877 | |
Oct 21 2001 | BECOURT, PHILIPPE | AVENTIS PHARMA S A | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 012358 | /0877 |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |